3Tzilas V, Koti A, Papandrinopoulou D, et al. Prognostic factors in idiopathic pulmonary fibrosis[J]. Am J Med Sci,2009,338(6) :481 - 485.
4Atzori L, Chua F, Dunsmore SE, et al. Attenuation of bleomycin-induced pulmonary fibrosis in mice using the heine oxygenase inhibitor Zn- deuteroporphyrin Ⅸ-2,4-bisethylene glycol[J]. Thorax, 2004, 59(3) :217-223.
5Lazar MH, Christensen PJ, Du M, et al, Plasminogen activator inhibitor-1 impairs alveolar epithelial repair by binding to vitronectin[J]. Am J Respir Cell Mol Biol,2004,31 (6):672-678.
6Otsuka M,Takahashi H, Shiratori M, et al., Reduction of bleomycin induced lung fibrosis by candeartan cilexetil, an angiotensin Ⅱ type 1 receptor antagonist [ J ]. Thorax, 2004,59 ( 1 ) : 31-38.
7Tager AM,Kradin RL, LaCamera P, et al. Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10[J]. Am J Respir Cell Mol Bid ,2004.31 (4) :395-404.
8Murakami S, Nagaya N, Itoh T, et al. C-type natriuretic peptide attenuates bleomycin-induced pulmonary fibrosis in mice[J]. Am J Physiol Lung Cell Mol Physiol,2004,287(6): 1172-1177.
9Kimura T,Ishii Y,Morishima Y, et al. Treatment with α-Galactosylce-ramide attenuates the development of bleomycin-lnduced pulmonary fibrosis[J] .J Immunol,2004,172(9) :5782-5789.
10Nakatani-Okuda A, Ueda H, Kashiwamura SI. et al. Protection against bteomycin-induced lung injury by IL-18 in mice[J]. Am J Physiol Lung Cell Mol Physiol, 2005,289 (2) : L280-287.
